Trotz beträchtlicher Anstrengung Malaria zu kontrollieren bzw. zu eradizieren, stellt die Krankheit weiterhin eines der gravierendsten Gesundheitsprobleme unseres Jahrtausends dar. Malaria fordert jährlich zwischen 0,7 und 2,7 Millionen Menschenleben, beeinträchtigt schulische und soziale Entwicklung und hemmt erheblich das Wirtschaftswachstum der betroffenen Länder. In Burkina Faso, einem der ärmsten Länder der Welt, ist Malaria eines der größten Gesundheitsprobleme und ca. ein Drittel aller Todesfälle werden hier Malaria angelastet. Die sich weiter ausbreiteten Resistenzen gegen die gängigen Malariamedikamente machen die Bekämpfung der Malaria zunehmend schwierig. Artemisinin basierende Kombinationstherapien sind aktuell, trotz relativ hoher Therapiekosten und erster Resistenzen, die Erstlinien Behandlung. Effektive und billige neue Kombinationstherapien werden dringend benötigt. In dieser Doktorarbeit wurde das Resistenzpotential von Artemisinin modelliert. Die Homologiemodellierungen unterstützen die These von Krishna und Kollegen von SERCA als einzige Zielstruktur von Artemisinin. Des Weiteren wurde Methylenblau als neues altes Malariamittel evaluiert. Methylenblau ist das erste gegen Malaria eingesetzte Medikament, agiert als ein prooxidatives Agens und inhibiert selektiv und nicht-kompetitiv die P. falciparum Glutathion Reduktase. Die additiven und multiplen Zielprotein Effekte von Methylenblau wurden experimentell untersucht und hier in einem bioinformatischem Modell getestet. Unter dem Einfluss von Methylenblau werden einige Schlüsselenzyme des Redoxstoffwechsels in ihrer Aktivität beeinträchtigt und der Parasit wird verstärkt oxidativem Stress ausgesetzt. Des Weiteren konnte in dieser Dr. Arbeit eine starke Kooperationsbereitschaft der urbanen und ländlichen Bevölkerung an zukünftigen Malaria Projekten gezeigt werden. / Dispite numerous global efforts malaria remains one of the biggest challenges of our millennium. Between 0,7-2,7 million people die from malaria each year. The disease is estimated to be responsible for an annual reduction of economic growth and hampers social und mental development. In Burkina Faso, one of the poorest countries in the world, malaria is the main health challenge and malaria is estimated to be responsible for one third of all death there. The fight against malaria has to cope with more and more resistance. Artemisinin-based combination therapies remain the first line treatment against malaria even when therapy is expensive and resistances are starting to appear. Effective and cheap combination therapies are needed. In this thesis resistance potential of the standard drug Artemisinin was modelled. The structure model data support the results by Krishna and co-workers that this is a principal target for Artemisinins. Furthermore the complementary aspects in order to introduce methylene blue (MB) combination therapies were examined. Methylene blue, the first synthetic drug ever used against malaria, is a subversive substrate and specific inhibitor of P. falciparum glutathione reductase. The additive and multi-target effects of MB are here both modelled and tested regarding redox network attack in the malaria parasite. Under the influence of MB enzyme participating in redox protection are switched of and the parasite is exposed to oxidative stress. Furthermore it could be shown a convincing commitment of rural and urban populations in Burkina Faso to eradicate malaria using a MB combination drug.

Zugl.: Giessen, Univ., Diss., 2008

Zugl.: Giessen, Univ., Diss., 2008

Universiẗat, Diss., 2008--Giessen.

The photocatalytic degradation of the wastewater dye pollutant methylene blue (MB) at ZnO nanostructured porous thin films, deposited by direct current reactive magnetron sputtering on Si substrates, was studied. It was observed that over 4 photocatalytic cycles (0.3 mg · l−1 MB solution, 540 minUV irradiation), the rate constant k of MB degradation decreased by ∼50%, varying in the range (1.54 ÷ 0.78) · 10–9 (mol·l−1·min−1). For a deeper analysis of the photodegradation mechanism, detailed information on the nanostructured ZnO surface morphology and local surface and subsurface chemistry (nonstoichiometry) were obtained by using scanning electron microscopy (SEM) and x-ray photoelectron spectroscopy (XPS) as complementary analytical methods. The SEM studies revealed that at the surface of the nanostructured ZnO thin films a coral reef structure containing polycrystalline coral dendrites is present, and that, after the photocatalytic experiments, the sizes of individual crystallites increased, varying in the range 43 ÷ 76 nm for the longer axis, and in the range 28 ÷ 58 nm for the shorter axis. In turn, the XPS studies showed a slight non-stoichiometry, mainly defined by the relative [O]/[Zn] concentration of ca. 1.4, whereas [C]/[Zn] was ca. 1.2, both before and after the photocatalytic experiments. This phenomenon was directly related to the presence of superficial ZnO lattice oxygen atoms that can participate in the oxidation of the adsorbed MB molecules, as well as to the presence of surface hydroxyl groups acting as hole-acceptors to produce OH· radicals, which can be responsible for the generation of superoxide ions. In addition, after experiments, the XPS measurements revealed the presence of carboxyl and carbonyl functional groups, ascribable to the oxidation by-products formed during the photodegradation of MB.